Trademark: 86726994
Status Date
Friday, March 15, 2024
Registration Number
5163878
Registration Date
Tuesday, March 21, 2017
Filing Date
Monday, August 17, 2015
Published for Opposition
Tuesday, October 18, 2016
5 Pharmaceutical preparations and substances for [the treatment and ] prevention of [ blood disorders, bleeding disorders, and ] diseases caused by [ bacteria and ] viruses; vaccines; [ blood products, namely, immunoglobulins for medical or clinical use; medicated serums for the treatment of influenza; anti-virals; ] influenza vaccines; adjuvants and antigens for medical purposes; [ blood products, namely, blood plasma, reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, namely, anti-venoms; medicated serums for the treatment of blood disorders and bleeding disorders; test kits, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, Rheysys Factor D Antigen reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies and Immunoglobulin subtypes; ] pharmaceutical preparations, namely, therapeutic monoclonal and polyclonal antibodies and antibodies for use in the treatment of infectious diseases [ ; pharmaceutical preparations, namely, reagents for medical and clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes ]
1 [ Chemical and biological reagents for scientific and non-medical purposes; cell cultures and media for laboratory, scientific and research use; test kits for scientific and non-medical laboratory use for anti-body screening, blood grouping or detection of specific blood cells, antigens and immunoglobulin subtypes; chemical preparations for scientific and industrial purposes; diagnostic and testing agents for scientific and non-medical purposes; Chemical and biological reagents for non-medical purposes; chemical and biological reagents for industrial use for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for industrial use for anti-body screening, blood grouping, and the typing and detection of specific blood cells ]
44 Medical services; medical information services; health care services; health care information services, namely, internet-based health care information services; [ providing medical information concerning blood products; ] providing medical information concerning vaccines [, anti-venoms and immunohematology products, namely, diagnostic reagents; patient support services, namely, providing an Internet-based database of patient medical information, where patients can enquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community ]
Mar 15, 2024
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Mar 15, 2024
Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Mar 15, 2024
Case Assigned To Post Registration Paralegal
Sep 21, 2023
Teas Section 8 & 15 Received
Mar 21, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Nov 25, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 25, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 18, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 18, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 21, 2017
Registered-Principal Register
Feb 14, 2017
1(B) Basis Deleted; Proceed To Registration
Jan 5, 2017
Notice Of Allowance Cancelled
Jan 21, 2017
Case Assigned To Intent To Use Paralegal
Jan 5, 2017
Teas Delete 1(B) Basis Received
Dec 13, 2016
Noa E-Mailed - Sou Required From Applicant
Oct 18, 2016
Official Gazette Publication Confirmation E-Mailed
Oct 18, 2016
Published For Opposition
Sep 28, 2016
Notification Of Notice Of Publication E-Mailed
Sep 13, 2016
Law Office Publication Review Completed
Sep 8, 2016
Approved For Pub - Principal Register
Sep 7, 2016
Examiner's Amendment Entered
Sep 7, 2016
Notification Of Examiners Amendment E-Mailed
Sep 7, 2016
Examiners Amendment E-Mailed
Sep 7, 2016
Examiners Amendment -Written
Sep 1, 2016
Teas/Email Correspondence Entered
Sep 1, 2016
Correspondence Received In Law Office
Aug 25, 2016
Assigned To Lie
Aug 18, 2016
Teas Response To Office Action Received
Jul 1, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 1, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 24, 2016
Notification Of Non-Final Action E-Mailed
Jun 24, 2016
Non-Final Action E-Mailed
Jun 24, 2016
Non-Final Action Written
Jun 3, 2016
Teas/Email Correspondence Entered
Jun 2, 2016
Correspondence Received In Law Office
Jun 2, 2016
Teas Response To Office Action Received
Jun 2, 2016
Teas Change Of Correspondence Received
Dec 3, 2015
Notification Of Non-Final Action E-Mailed
Dec 3, 2015
Non-Final Action E-Mailed
Dec 3, 2015
Non-Final Action Written
Dec 1, 2015
Assigned To Examiner
Aug 20, 2015
New Application Office Supplied Data Entered
Aug 20, 2015
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
